Lakewood-Amedex Biotherapeutics logo
Lakewood-Amedex Biotherapeutics, Inc. (LABT)
NASDAQ: LABT · Real-Time Price · USD
0.7822
-0.0098 (-1.24%)
At close: Oct 9, 2026, 4:00 PM EDT
0.7704
-0.0118 (-1.51%)
After-hours: Oct 9, 2026, 7:49 PM EDT

LABT Statistics

Total Valuation

LABT has a market cap or net worth of $1.85 million. The enterprise value is -$2.63 million.

Market Cap1.85M
Enterprise Value -2.63M

Important Dates

The next estimated earnings date is Wednesday, November 18, 2026, before market open.

Earnings Date Nov 18, 2026
Ex-Dividend Date n/a

Share Statistics

LABT has 2.37 million shares outstanding. The number of shares has increased by 27.02% in one year.

Current Share Class 2.37M
Shares Outstanding 2.37M
Shares Change (YoY) +27.02%
Shares Change (QoQ) +102.96%
Owned by Insiders (%) 51.19%
Owned by Institutions (%) 5.38%
Float 847,670

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.39
P/TBV Ratio 0.43
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.70, with a Debt / Equity ratio of 0.02.

Current Ratio 7.70
Quick Ratio 7.29
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -58.40

Financial Efficiency

Return on equity (ROE) is -402.84% and return on invested capital (ROIC) is -166.20%.

Return on Equity (ROE) -402.84%
Return on Assets (ROA) -139.40%
Return on Invested Capital (ROIC) -166.20%
Return on Capital Employed (ROCE) -167.83%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 1.92
200-Day Moving Average n/a
Relative Strength Index (RSI) 25.13
Average Volume (20 Days) 2,403,282

Short Selling Information

The latest short interest is 52,967, so 2.24% of the outstanding shares have been sold short.

Short Interest 52,967
Short Previous Month 61,402
Short % of Shares Out 2.24%
Short % of Float 6.25%
Short Ratio (days to cover) 0.04

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -7.27M
Pretax Income -7.35M
Net Income -8.97M
EBITDA -7.26M
EBIT -7.27M
Earnings Per Share (EPS) -$10.20
Full Income Statement

Balance Sheet

The company has $4.58 million in cash and $101,619 in debt, with a net cash position of $4.48 million or $1.89 per share.

Cash & Cash Equivalents 4.58M
Total Debt 101,619
Net Cash 4.48M
Net Cash Per Share $1.89
Equity (Book Value) 4.33M
Book Value Per Share 2.00
Working Capital 4.22M
Full Balance Sheet

Cash Flow

Operating Cash Flow -3.49M
Capital Expenditures n/a
Depreciation & Amortization 4,634
Net Borrowing n/a
Free Cash Flow -3.49M
FCF Per Share -$1.47
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

LABT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -27.02%
Shareholder Yield -27.02%
Earnings Yield -484.20%
FCF Yield -188.06%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on June 22, 2026. It was a reverse split with a ratio of 1:10.

Last Split Date Jun 22, 2026
Split Type Reverse
Split Ratio 1:10

Scores

Altman Z-Score n/a
Piotroski F-Score 2